Biocon Biologics Profile
Key Indicators
- Authorised Capital ₹ 3,500.00 Cr
- Paid Up Capital ₹ 1,758.31 Cr
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 16,501.50 Cr
- Satisfied Charges ₹ 10,141.76 Cr
About Biocon Biologics
Biocon Biologics Limited (BBL) is a Public Limited Indian Non-Government Company incorporated in India on 08 June 2016 (Eight years and eight months 21 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as Biocon Biologics India Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3,500.00 Cr and a paid-up capital of Rs 1,758.31 Cr.
The company currently has active open charges totaling ₹16,501.50 Cr. The company has closed loans amounting to ₹10,141.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Biocon Biologics Limited India are Shreehas Tambe as Ceo, Akhilesh Nand as Company Secretary, and Mr Upadhye as Cfo. Bobby Parikh, Rajiv Malik, Daniel Bradbury, and Seven other members serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24119KA2016PLC093936
- Company No.
093936
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2016
- Date of AGM
26 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Pharma
Who are the key members and board of directors at Biocon Biologics?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shreehas Tambe  | Managing Director | 05-Dec-2022 | Current |
| Akhilesh Nand | Company Secretary | 21-Aug-2024 | Current |
| Mr Upadhye | CFO | Current |
Board Members (9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nivruti Rai  | Director | 01-Aug-2019 | Current |
| Kiran Shaw | Whole-Time Director | 08-Jun-2016 | Current |
| Daniel Bradbury | Director | 01-Aug-2019 | Current |
| Bobby Parikh | Director | 01-Aug-2019 | Current |
| Rajiv Malik | Nominee Director | 29-Nov-2022 | Current |
Peter Piot  | Director | 21-Jan-2021 | Current |
Financial Performance of Biocon Biologics.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Biocon Biologics?
Unlock access to Biocon Biologics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mylan Laboratories LimitedRajiv Malik is a mutual person
Science Gallery BengaluruKiran Shaw is a mutual person
Mazumdar Shaw Medical FoundationKiran Shaw is a mutual person
Immuneel Therapeutics Private LimitedKiran Shaw is a mutual person
Trent LimitedKiran Shaw is a mutual person
Csep Research FoundationKiran Shaw is a mutual person
Charges (Loans)
Open Charges
₹16,501.50 Cr
Satisfied Charges
₹10,141.76 Cr
Charges Breakdown by Lending Institutions
- Others : 16151.50 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 350.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Dec 2024 | Others | ₹847.30 Cr | Open |
| 22 Nov 2024 | Others | ₹6,808.76 Cr | Open |
| 03 Mar 2023 | Others | ₹7,947.94 Cr | Open |
| 30 Oct 2020 | The Hongkong And Shanghai Banking Corporation Limited | ₹350.00 Cr | Open |
| 14 Dec 2018 | Others | ₹547.50 Cr | Open |
How Many Employees Work at Biocon Biologics?
Unlock and access historical data on people associated with Biocon Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biocon Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biocon Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
